Enhancing Prospective Thinking in Early Recovery
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Alcohol Use Disorder
- Sponsor
- Indiana University
- Enrollment
- 500
- Locations
- 1
- Primary Endpoint
- Increased Length of Abstinence
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
The goal of this clinical trial is to use a novel virtual reality intervention to test for efficacy in reducing alcohol use and increasing abstinence, with concomitant increases in future self-identification, future time perspective, and delay-of-reward, in early recovering alcohol use disorder (AUD) persons. The main question[s] this trial aims to answer are:
Will the Virtual Reality (VR) intervention decrease the number of stimulant use days? Will the VR intervention produce longer abstinence periods during follow-up visits? Will the VR intervention increase alcohol abstinence rates? Will the VR intervention increase future self-identification? Will the VR intervention increase self-reported future time perspective? Will the VR intervention increase preference for delayed rewards in a laboratory delay discounting task on the study day? Will the VR intervention produce gains in the behavioral effects of future self-identification, future time perspective, and delayed rewards at the 30-day and 6-month follow-ups? Researchers will compare the experimental and control groups to see if there are differences in the results for the questions outlined above.
Investigators
Brandon G. Oberlin, PhD
Assistant Professor
Indiana University
Eligibility Criteria
Inclusion Criteria
- •Abstinence between ≥14 days and ≤1 year
- •Verbal endorsement of commitment to recovery
- •Outpatient
- •Psychotropic drugs for SUD-comorbidity
- •Drug/alcohol abstinence ≥ 24 hours at the time of the study day visit
- •English comprehension
Exclusion Criteria
- •Unstable medical disorders
- •Habitual drug use
- •Mu-opioid drugs
- •Smell/taste disorders
- •Unstable psychiatric conditions
- •Extravagant/elaborate face tattoos
Outcomes
Primary Outcomes
Increased Length of Abstinence
Time Frame: Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit.
The Virtual Reality Avatar experience will increase the length of abstinence periods.
Future Time Perspective with the Delayed Discounting Behavioral Task and Future Self Continuity Questionnaire
Time Frame: Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit.
The Virtual Reality Avatar experience will increase future time perspective.
Reduced Use of Drug Using Days
Time Frame: Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit
The Virtual Reality Avatar experience will reduce drug using days.
Increased (overall) Abstinence
Time Frame: Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit.
The Virtual Reality Avatar experience will increase abstinence.
Delayed Reward Preference with the Delayed Discounting Behavioral Task
Time Frame: Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit.
The Virtual Reality Avatar experience will increase preference for delayed rewards.
Future Self-identification with Future Self Continuity Questionnaire
Time Frame: Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit
The Virtual Reality Avatar experience will increase future self-identification.